University of Arkansas, Fayetteville

ScholarWorks@UARK
Graduate Theses and Dissertations
12-2017

Evaluation of The Impact of Tart Cherries Polyphenols on The
Human Gut Microbiota and Phenolic Metabolites In Vitro and In
Vivo
Alba Claudia Mayta-Apaza
University of Arkansas, Fayetteville

Follow this and additional works at: https://scholarworks.uark.edu/etd
Part of the Food Microbiology Commons, Food Studies Commons, and the Fruit Science Commons

Citation
Mayta-Apaza, A. C. (2017). Evaluation of The Impact of Tart Cherries Polyphenols on The Human Gut
Microbiota and Phenolic Metabolites In Vitro and In Vivo. Graduate Theses and Dissertations Retrieved
from https://scholarworks.uark.edu/etd/2612

This Thesis is brought to you for free and open access by ScholarWorks@UARK. It has been accepted for inclusion
in Graduate Theses and Dissertations by an authorized administrator of ScholarWorks@UARK. For more
information, please contact scholar@uark.edu.

Evaluation of The Impact of Tart Cherries Polyphenols on The Human Gut
Microbiota and Phenolic Metabolites In Vitro and In Vivo

A thesis submitted in partial fulfillment
of the requirements for the degree of
Master of Science in Food Science

by

Alba Claudia Mayta Apaza
Escuela Agrícola Panamericana, El Zamorano
Bachelor of Science in Food Technology, 2013

December 2017
University of Arkansas

This thesis is approved for recommendation to the graduate Council.

Dr. Franck Carbonero
Thesis Director

Dr. Ravi Barabote
Committee Member

Dr. Luke Howard
Committee Member

1

Abstract

Tart cherries are polyphenol abundant stone fruits claimed to exert health benefits further
of its nutritional properties. The abundant phytochemicals content in tart cherries also referred as
dietary polyphenols have been considered as an effective natural antioxidant when added in daily
diet. However, it has been hypothesized the intervention of gut microbiota on the overall
functionality of such compounds. This thesis contains a wide-ranging literature review focused on
tart cherry as a crop, current market, functional food, and several health benefits. Furthermore, the
research done describes and in vitro and in vivo assays of a short-term dietary intervention of tart
cherry and polyphenol isolates assessed with microbial ecology analysis and metabolomics of tart
cherry concentrate polyphenols and microbial metabolites. The concentration of polyphenols
(anthocyanins, flavonols and phenolic acids) were high amounts as expected. The in vitro assay
showed large increase of Bacteroides in addition to a suggested Bifidobacterium increase likely
due to large concentration of chlorogenic acid found in the tart cherry concentrated juice. The main
microbial metabolites found in this assay was mainly 4-hydroxyphenyl propionic acid and in less
amounts 4-hydroxybenzoic acid. The in vivo assay showed two initial scenarios associates with
Bacteroides relative abundance: individuals with high Bacteroides increase the relative abundance
of Lachnospiraceae, Ruminococcus and Collinsella; on the other hand, individuals with low levels
of Bacteroides responded with an increase Prevotella and Bifidobacterium and Bcteroides and
decrease of Lachnospiraceae, Ruminococcus and Collinsella. The results confirm an intervention
from the gut microbiota over the metabolism of phytochemicals which should be considered in
studies linked with functional foods and potential benefits to health.
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ABSTRACT
Tart cherries are increasingly popular due to purported health benefits. This Prunus cesarus
species is cultivated worldwide, and its market has increased significantly in the last two decades
due to improvements in agricultural practices and food processing technology. Tart cherries are
rich in polyphenols, with a very specific profile combining anthocyanins and flavonols (berrieslike) and chlorogenic acid (coffee-like). Tart cherries have been suggested to exert several
potentially beneficial health effects including: lowering blood pressure, modulating blood glucose,
enhancing cognitive function, protecting against oxidative stress and reducing inflammation.
Studies focusing on tart cherry consumption have demonstrated particular benefits in recovery
from exercise-induced muscle damage and diabetes associated parameters. However, the
bioconversion of tart cherry polyphenols by resident colonic microbiota has never been considered,
considerably reducing the impact of in vitro studies that have relied on fruit polyphenol extracts.
In vitro and in vivo gut microbiota and metabolome studies are necessary to reinforce health claims
linked to tart cherries consumption.
Keywords:
Tart cherries, Phytochemicals, Polyphenols, Gut microbiota, Metabolome
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INTRODUCTION
Tart cherries (Prunus cerasus) are among the ever-growing list of fruits branded as “superfoods”. While the superfood concept tends to often rely on speculative assertions, the potential
health benefits of tart cherries are relatively well documented. The significantly high
phytochemical content in tart cherries (especially polyphenols) has most commonly been studied
in the context of health, and there is solid evidence for high antioxidant properties at the very least
(Blando et al. 2004,Ducharme et al. 2009,Levers et al. 2016,Matchynski et al. 2013,Wojdylo et al.
2014).
Functional food is a term broadly used to label foods that help to enhance some functions
of the body as well as being nutritious (Hasler. 1996). It is important to note that “qualified health
claims” are stringently regulated by FDA, and thus only few foods marketed as functional foods
have strong scientific evidence of bringing health benefits. Therefore, tart cherries, like other
phytochemical-rich fruits, do not fulfill specific health claims (however, like most fruits and
vegetables containing fibers and vitamins, they fulfill the general claims for reduced coronary heart
disease and cancer risk). Still, there have been numerous reports of beneficial health impacts from
consumption of phytochemical-rich fruits (Nile and Park. 2014). Tart cherries are particularly rich
in polyphenolic compounds such as flavonoids: flavonols and anthocyanins; anthocyanins being
responsible for the deep red color characteristic of the fruits (Damar and Eksi. 2012, Alrgei et al.
2016).
Several studies in recent years have suggested specific beneficial health properties from
tart cherry consumption, notably a potential to alleviate muscle damage commonly associated with
prolonged physical effort (Connolly et al. 2006 ,Kuehl et al. 2010,Kuehl. 2012). Tart cherries
potential for prevention of chronic diseases such as cancer (Kang et al. 2003, Martin and Wooden.
3

2012) and cardiovascular abnormalities (Juhasz et al. 2013,Bak et al. 2006,Csiki et al. 2015),
diabetes (Mahmoud et al. 2013) as well as inflammatory conditions (Ou et al. 2012,Saric et al.
2009) has also been reported. However, a significant portion of research has relied on in vitro or
animal studies with isolated native polyphenolic extracts (in particular, antioxidant properties)
(Kirakosyan et al. 2015,Kirakosyan et al. 2009,Mahmoud et al. 2014). Polyphenols, which are
large and complex molecules, are known to be generally poorly absorbed in the small intestine. It
has been shown that the colonic microbiota (the collection of microbes living in the large intestine)
modifies and degrades polyphenols to smaller metabolites which become available to the host
(Bohn. 2014, Bohn et al. 2015, Crozier et al. 2009). There is still only sparse knowledge on how
fruit polyphenols modulate the gut microbiota, and into which metabolites they break down
through colonic fermentation (Del Rio et al. 2013a). This represents a major limitation for previous
in vitro studies using native polyphenols, since human cells/organs are most likely to be exposed
to phenolic metabolites (Aura et al. 2013,Clifford et al. 2013,Larrosa et al. 2009a,Miene et al.
2011). Further, the strong individuality in human gut microbiota profiles (Turroni et al.
2017,Arumugam et al. 2011) and microbiome functions arguably leads to different metabolome
profiles (Bolca et al. 2013,Tomas-Barberan et al. 2016). The goal of this review is to present the
current knowledge on tart cherries as a high value crop and describe the reported potential health
benefits. The limited knowledge on gut microbiota modulation of tart cherries phytochemicals will
also be presented.
TART CHERRY ECONOMIC IMPORTANCE

Cherry trees (genera Prunus) are represented by two subgenera, Padus (bird cherries) and
Cesarus, however most berries of agricultural importance belong to the Cesarus subgenus. More
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specifically, the two-main species grown worldwide are Prunus avium (sweet cherries) and Prunus
cesarus (tart or sour cherries) (Brown-Skrobot et al. 1989). Cherries are considered high-value
crop produced worldwide largely because of their purported health benefits (Bak et al. 2010, Bell
et al. 2014a) rather than organoleptic properties. The current review will be focused on tart
cherries.
Worldwide, tart cherries production has increased significantly in the last decades because
of advances in agricultural practices, food technologies and raising global demand; from 2,154,000
to 3,057,000 metric tons. Europe leads the production with 65.8% of the total world production
followed by Asia and America with 24.9% and 9.3% respectively (FAOSTAT, 2015). In 2013, the
top five producer countries of tart cherry were Ukraine, Russian Federation, Poland, Turkey and
the United States of America (USA). The USA produced 268,072 metric tons in 2013 and 2014
valued at more than $210 million. Michigan, Utah, and Washington are the three states with the
highest production (USDA NASS, 2014). During the past decade, USA has been a leading exporter
of this commodity and lately Chile has joined the export market, mainly to China, Russia and
South Korea. Tart cherry production has increased due to recent improvement in agricultural
practices, allowing producers to sell fruits at reasonable prices (Webster and Looney. 1995), before
necessary processing into concentrate, juice, wine, brined, dried and powder, which have better
palatability (Kirakosyan et al. 2009, Webster and Looney. 1995).
PRE AND POST-HARVEST AND PROCESSING SPECIFICITIES

Tart cherry cultivars are the most tolerant plants to biotic and abiotic stress among their
family (Rosaceae). However, during harvest tart cherries become susceptible to hot-dry weather,
which reduces the harvest window and can be the cause of significant physico-chemical changes
5

affecting color, polyphenol content and the detachment force, thus affecting the overall production
(Aslantas et al. 2016). Appropriate harvest and postharvest handling are critical for higher quality
of the commodity, however 55% of the total cost is spent when cherries are hand-harvested. In
contrast mechanical harvesting was shown to lower the cost and enhance profits for the industry
(Webster and Looney. 1995).
Tart cherry is a non-climacteric fruit, thus the variability of maturity throughout the tree
influences quality and yields during harvest and processing. Industrial tart cherry processors rely
on methods to determine optimum physio-chemical parameters of maturity including the fruit
detachment force (FDF) and color parameters (Aslantas et al. 2016) . The color characteristics,
specifically the color intensity, have been reported to be an effective field indicator of maturity
stage in cherry. Aslantas et al. ( 2016) researched a standard procedure to determine the degree of
maturity for harvest based on the fruit detachment force and fruit pomological and chemical
characteristics. Tart cherries were classified into five stages of maturity per physical characteristics
such as color and size by observation, where higher values meant higher level of maturity. The
results indicated a strong relation between the physicochemical characteristics and the stage of
maturation in the fruit; where the best three categories of maturity stages showed higher efficiency
in poundage per tree, as well as improved homogeneity of color and reduced fruit detachment
force. Ascorbic acid levels tend to decrease when maturity increases as degradation of organic
acids occur, which is a desirable quality in the juice industry (Wojdylo et al. 2014,Karaaslan et al.
2016).
Around 95% of the tart cherry production is intended for industrial purposes; representing
a great challenge for new processing technologies able to preserve bioactive compounds available
for consumption. The production of juice accounts for about half of the tart cherry production
6

destined to industry. Turkey, one of the largest producers, utilizes around forty percent of the tart
cherries in production of juice or nectar because of the market demand and accessible handling for
commercialization (Damar and Eksi. 2012). The rest of the production is distributed into frozen,
purees, dried pitted tart cherry, powder from individually quick frozen (IQF), and concentrates.
Every product undergoes different treatment technologies that have an impact on the content of
bioactive compounds which varies according to the type of product. Table 1 presents an exhaustive
list of the processing steps that tart cherries undergo to be converted to juice. In the production of
juice, mash press extraction has been shown as the key step for optimal phenolic compounds
recovery. To improve extraction three rinses are necessary to increase the recovery yield of
bioactive compounds, reaching 83% of anthocyanin and 62% of procyanidins (oligomeric
flavonoids) from the press cake (Toydemir et al. 2013b). The total extraction of these compounds
is remarkably high in comparison to other fruits such as blueberries (Skrede et al. 2000); and two
properties may explain this phenomenon. First, the molecular structure of the anthocyanin profile
in tart cherry is dominated by water soluble chemical groups (tri-glycoside), which may increase
the recovery of anthocyanins. Second, anthocyanins in the fruits are found mainly in the flesh
facilitating disruption and enabling a higher yield of bioactive compounds in the end-product
(Capanoglu et al. 2013,Toydemir et al. 2013a). Transformation of rich polyphenol plants tissues
to processed products leads to changes in the phenolic profile with the formation of derived
polyphenols (Crozier et al. 2009). The addition of sweeteners in cherry products has been shown
to induce a slight decline in polyphenol concentration, especially the anthocyanins. Nevertheless,
these products are more attractive to consumers and are still able to provide a high antioxidant
activity and potential health benefits (Nowicka and Wojdylo. 2016).
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Nutritional and health claims have substantially increased the demand of tart cherry in the
industry and have generated interest of research in preservation and stability of the phytochemicals
content and bioavailability in tart cherry after processing (Seeram et al. 2001a). During processed
tart cherry products storage, physicochemical reactions take place where the antioxidant
compounds are converted or degraded, and color may be altered. The concentration of
polyphenolic compounds can also change due to enzymatic oxidation to quinones (Bonerz et al.
2007). Monomeric anthocyanins are the most affected by the storage steps that the products
undergo. Furthermore, long term storage had been reported to affect the polyphenol profile and
contents. Storage at 20°C for 6 months resulted in formation of polyphenol derivatives and
significant decline (70–75%) of anthocyanin concentration (Bonerz et al. 2007). Also since this
last step is key, packaging alternatives were tested to identify the most effective storage route for
product quality (freeze-dried sour cherry) and polyphenols integrity. This study showed that most
of polyphenols remain stable and in high concentration except anthocyanins which decreased by
62% after one-year storage at lower temperatures (Zoric et al. 2016). This kind of food storage
allow year-round tart cherry products availability, hence proper food processing practices to
preserve the bioactive components is beneficial not only for the industry but for the consumers.
TART CHERRY PHYTOCHEMICALS

Phytochemicals are secondary metabolites, non-nutritive molecules produced naturally by
plants (Dillard and German. 2000) as a response to abiotic and biotic stress especially climate
variation, mechanical damage, as well as a response to pathogen attack (Hirschi. 2009). Certain
secondary metabolites are classified as phytochemicals if their chemical structure can provide
potential health benefits over basic nutritional value (Dillard and German. 2000,Tsao. 2010).
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Phytochemical profiles are extremely variable across plant species (and even variety/cultivar); and
environmental factors such as growth conditions, soil type and seasons result in further variability
(Hirschi. 2009, Webster and Looney. 1995).
Cherries in general have been described as phytochemical rich fruits with potential health
benefits, while reports on their phytochemical profiles have been somewhat conflicting
(Kirakosyan et al. 2009,Kirakosyan et al. 2010,Ou et al. 2012). While there is convincing evidence
that phytochemicals in general are safe to consume, one should remember that in vitro experiments
that constitute a large fraction of our current knowledge are only partially representative of actual
human metabolism and physiology (Nile and Park. 2014, Steinberg et al. 2003, Amin et al. 2015,
Bak et al. 2006). Moreover, the interaction between phytochemicals may result in changes in
physio-chemical characteristics such as solubility, stability and bioavailability of the active
compounds in the products (Kirakosyan et al. 2010). Total polyphenol, monomeric anthocyanins,
and ascorbic acid are well known to possess remarkable anti-oxidant properties (Moyer et al.
2002,Seeram et al. 2008, Del Rio et al. 2013b, Landete. 2012, Redondo et al. 2017). However,
most of the antioxidant response was thought to come from the anthocyanins fraction but it actually
derives mostly from phenolic acids (Damar and Eksi. 2012).
The phytochemicals in tart cherries are carotenoids and phenolics: phenolic acids and
flavonoids (Damar and Eksi. 2012, Blando et al. 2004, Kirakosyan et al. 2009).
Phenolics

Phenolics are secondary metabolites produced by plants which have at least one aromatic
ring with a single or several hydroxyl groups attached, ranging from simple low molecular weight
up to complex large molecules such as tannins. Some phenolics are synthesized from
9

carbohydrates following shikimate and phenyl propanoid pathways (Ferretti et al. 2010) . The
distribution and concentration of phenolics varies within each tree and within the fruit as shown in
Table 2. Montmorency tart cherry cultivar have highest phenolic content in their skin, leading to
higher antioxidant capacity (Chaovanalikit and Wrolstad. 2004). The synthesis and accumulation
of phenolics in the skin is used as a natural harvest indicator, provides organoleptic characteristics
to the fruit constituting a natural defensive mechanism.

The phenolic compounds in tart cherry contribute to their sensorial attributes like color and
flavor (Ferretti et al. 2010) (Table3). There is also a great interest on the preventive functionality
that phenolic compounds have shown in several animal and human models exposed to chronic
and/or long-term diseases such as, cancer or diabetes and associated features such as oxidative
stress.
For a clearer understanding, phenolic compounds are classified into flavonoids and non-flavonoids
(Bravo. 1998, Tsao. 2010).
Flavonoids

Flavonoids have attracted interest because of their influence as health promoter
compounds. The widely-studied anthocyanins are well known for their antioxidant capacity
(Casedas et al. 2016,Khoo et al. 2012,Wojdylo et al. 2014)(Khoo and others 2011; Wojdylo and
others 2014b; Casedas and others 2016; Nowicka and others 2016). Other flavonoids include
flavonols, flavones, flavanols, flavanones, and isoflavones. Flavonoids are recognized for their
ability of scavenge hydroxyl and peroxyl radicals and also function in synergy with other
antioxidants and other bio-compounds such as tocopherol and ascorbic acid.
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Anthocyanins

Anthocyanins are synthetized mainly during ripening and are responsible for the color
change from green to deep red (Karaaslan et al. 2016). Tart cherries have been shown to contain
high levels of anthocyanins and phenolic acids which have an inverse relationship: during early
stage the fruit is high in phenolic acids, while anthocyanins synthesis increases towards ripening
(Karaaslan et al. 2016,Wojdylo et al. 2014,Blando et al. 2004,Damar and Eksi. 2012), resulting
in the characteristic deep red color of tart cherries. Since color means such an important parameter
for harvest and sensorial control, Kim et al (Kim et al. 2005) also evaluated the total content of
anthocyanins in cherries using two approaches: a colorimetric assay and HPLC. While comparing
both methods the anthocyanin levels from both were almost the same, meaning that the total count
of anthocyanins colorimetric assays gave a similar result when compared with the sum of
individual anthocyanins analyzed with HPLC.
Several factors strongly affect the anthocyanin content such as genetic background and
environmental characteristics (Karaaslan et al. 2016) or if the tart cherries are analyzed as fresh
fruit or as processed product (Kirakosyan et al. 2009). However, the major fraction corresponds
to Cyanidin-3-glucosyl-rutinoside, accounting for approximately 70% of the total anthocyanin
concentration (Blando et al. 2004,Chaovanalikit and Wrolstad. 2004, Daenen et al. 2007, Kang et
al. 2003, Seeram et al. 2001, Tall et al. 2004). Anthocyanins have been reported to be the major
phenolic in tart cherries,in particular cyanidin and peonidin aglycones and anthocyanidins (Fang
2015) (Table 4).

Although, anthocyanins are the major compound in tart cherries, they are also the most
unstable and handling in industrial levels is a challenge (Chaovanalikit and Wrolstad. 2004,
11

Kirakosyan et al. 2009, Zoric et al. 2016). Vesna et al ( 2016) developed a cookie taking advantage
of the positive interaction between proteins and phenolics, resulting in a satisfactory retention of
anthocyanins (19-59%).
Flavonols

Flavonols are a subclass of flavonoids that are naturally produced by plants with important
antioxidant potential (Kirakosyan et al. 2009). The reported flavonols content in cherry products
vary significantly, this phenomenon can be due to several causes such as the kind of product itself,
the conditions it was subjected during processing as well as to the environmental and agricultural
conditions where the plant was grown (Toydemir et al. 2013b). In a study of interaction of isolated
polyphenols from tart cherry fruits, it was found that kaempferol and quercetin were the primary
contributors of the antioxidant (TEAC) properties (Kirakosyan et al. 2009), with Trolox equivalent
antioxidant capacity (TEAC) values of 4.5 mM TEAC and 4.2 mM respectively. The flavonols
reported from tart cherry products are kaempferol-3-rutinoside, quercetin-3-glucoside, quercetin3-rutinoside, quercetin-3-(2-glucosyl-rutinoside) and isorhamnetin rutinoside (Table 5). They
were found to be fairly stable in tart cherry juice stored six months at freezing temperature (-25°C)
(Bonerz and others 2007a; Li and others 2008).

Phenolic acids

Phenolic acids are non-flavonoid polyphenolic compounds recognized for their strong
antioxidant activity; and divided into two subclasses: hydroxyl-benzoic acids and hydroxylcinnamic acids. Recent studies reported that tart cherries are rich in chlorogenic and
neochlorogenic acids (Table 6), which have only been described in similarly high quantities in
12

coffee (Karaaslan and others 2016; Casedas and others 2016) and in lower abundances in apricots
and blueberries (Cho et al. 2004,Dragovic-Uzelac et al. 2007).

Carotenoids and other phytochemicals

While carotenoids are assumed to be present in tart cherries, there have been no reports on
detection and quantification specifically on tart cherries. Carotenoids, including α and β-carotens,
lutein and neoxanthin have been detected in wild cherries; however total carotenoids levels did not
exceed 12.6 mg/kg, whereas carotenoids-rich vegetables often contain hundreds of mg/kg of just
one of these carotenoids (Mikulic-Petkovsek et al. 2016). Carotenoids have been reported to be
present in sweet cherries (McCune et al. 2011), however original reports could not be tracked back.
Carotenoids were also detected in very low levels (0.02 mg/g DW) in cherries (presumably sweet)
in comparison with carrots and bell peppers in a study conducted in New Zealand (Leong and Oey.
2012).
The potentially antioxidant melatonin (N-acetyl-5-methoxytryptamine) had been reported in high
levels in tart cherries (Burkhardt et al. 2001), however more recent reports indicated that melatonin
was in low concentration in Montmorency and Balaton tart cherries and completely absent in
processed tart cherry products (Kirakosyan et al. 2009). Finally, tart cherries contain relatively low
(3-9 mg/100 g) amounts of ascorbic acid (Vitamin C) (Papp et al. 2010), confirming that tart
cherries antioxidant potential mainly derive from phenolic compounds.
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IMPACT ON NUTRITION AND HEALTH
There are several studies suggesting health promoting benefits could be associated to tart
cherries consumption including effects on chronic diseases such as cancer, diabetes and cardiac
complications (Bajerska et al. 2016, Czompa et al. 2014, Bobe et al. 2006, Martin and Wooden.
2012, Saleh et al. 2017). These studies have generally focused on the content and functionality of
phytochemicals of tart cherries and connected specifically with the antioxidant activity.
Nutrition

Tart cherry fruits have somewhat unremarkable nutritional composition (Table 7), with low
fiber and vitamin C content, but represent a good source of minerals and vitamin A. In addition,
the necessary food processing tends to even lower the contents of valuable nutrients. One
advantage is that unsweetened tart cherries products have low sugars and calories.
Tart cherries impact on exercise

The antioxidant effect phytochemicals in powdered tart cherry has been suggested to improve
muscle function recovery and reduce inflammation, oxidative stress and pain associated with
intensive exercise (Bell et al. 2014a). Consumption of tart cherry juice blend have been shown to
reduce significantly muscle damage symptoms caused by intensive strength exercise or running in
humans (Connolly et al. 2006,Kuehl et al. 2010,Howatson et al. 2010,Bowtell et al. 2011) and
horses (Ducharme et al. 2009).Tart cherries supplementation intake was shown to improve the
average of race pace, as well as modulating the balance in oxidative stress, decreasing
inflammation markers and improving muscle recovery (Levers et al. 2015,Levers et al. 2016).
Another study investigated the potential effect of tart cherry concentrate on muscle recovery after
prolonged and intermittent exercise such as soccer Tart cherry supplementation resulted in faster
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recovery and lower muscle soreness suggesting modulation of oxidative stress and inflammation
post-exercise (Bell et al. 2016). Similar results were reported in water-polo players consuming tart
cherry products (McCormick et al. 2016) as well as other type of high intensity exercise (Bell et
al. 2015) including cycling (Bell et al. 2014b). Another concern about extended exercise recovery
has to do with airway inflammation (respiratory mucosal inflammation) directly linked with
induced pulmonary stress. Tart cherry juices seemed to have a modulatory effect as well as
reducing inflammatory markers in the respiratory tract of healthy athletes, leading to faster
recovery (Dimitriou et al. 2015).
Antioxidant and anti-inflammatory potential

Tart cherries have been shown to modulate inflammatory and oxidative stress expression in
HAPI cells (rat microglial cells) such as nitric oxide, inducible nitric oxide synthase and
cyclooxygenase-2 in dose and time dependent manner (Shukitt-Hale et al. 2016a). The
inflammatory activity in the hippocampus of older rats, measured through COX-2 expression,
decreased significantly after six weeks of tart cherry supplementation (Thangthaeng et al. 2016).
Similar anti-inflammatory potential was observed in mice consuming tart cherry juice (Saric et al.
2009). A double-blind, placebo-controlled, crossover dietary intervention demonstrated that
consumption of tart cherry juice improved the ability of older men and women to resist oxidative
damage and stress (Traustadottir et al. 2009). Another study demonstrated that various tart cherry
products possessed remarkable antioxidant (ORAC properties), but that concentrates in particular
have higher anti-inflammatory properties as measured by COX-1 inhibition in vitro (Ou et al.
2012).

15

Tart cherry have also been used as supplementation for treatment of rheumatoid arthritis, in
this case tart cherry seeds were used to investigate its promoting health activity over inflammatory
disorder. Blood leukocytes from rheumatic arthritis patients were used and subjected to
lipopolysaccharide and seeds extract for 24 hours and was reported a decreased expression of heme
oxygenase-1 (inflammatory marker) that control oxidative stress and therefore intervene on
inflammation expression (Mahmoud et al. 2014,Mahmoud et al. 2013).

POTENTIAL IMPACT OF METABOLIC DISEASES
Diabetes and Obesity

Phenolic compounds have shown promising results associated with neutralization of development
and progression of diabetes and its complications (Lachin. 2014). Although further in vivo studies
are needed, this may represent an alternative to current treatments.
Two enzymes are in charge to hydrolyze carbohydrates: pancreatic alpha-amylase and
intestinal alpha-glucosidase needed to break down to monosaccharides. Therefore, one postulated
manner to control hyperglycemia and type 2 diabetes is to interfere the role of these enzymes.
Nowicka et al ( 2016) showed effective inhibition of those enzymes in in vitro assays through
consumption of smoothies made of tart cherry and other fruits rich in phytochemicals. Comparable
in vitro results were found with tart cherries anthocyanins having inhibitory activity towards alphaamylase (Homoki et al. 2016).
A recent study was carried out to evaluate the hypoglycemic effect of tart cherry extracts
in acute and sub-chronic injections to mice, both leading to dose-dependent restorative effects. The
acute injection resulted in a decrease of blood glucose level and the sub-chronic scenario an even
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stronger amelioration of glucose levels as well as effects on weight loss and oxidative stress and
significant pancreatic cell regeneration (Saleh et al. 2017). Another health problem associated with
diabetes is obesity and the harmful impact of adiposity over metabolism. Here again the
consumptions of tart cherry extracts also resulted in lower blood glucose in obese mice fed with
polyphenol-rich cherry extract after food deprivation. The extract consumption also reduced lipid
accumulation, adiposity accumulation in the liver tissue and remediate the uncontrolled
accumulation of fat cultured cells (Snyder et al. 2016) .
The potential to use by-products such as pomace of juice production has been considered
due to the elevated content of phytochemicals. A human randomized crossover trial (one test meal
followed by glycemic response measurements) was performed using tart cherry pomace as
ingredient of muffins replacing part of the flour (20 or 30%). The results in terms of controlling
glucose levels were similar to other studies mentioned before but the enriched muffins were also
effective managing hunger and food intake. Those food products could be a suitable alternative
for a healthy breakfast or snack in additions to its sensorial acceptance (Bajerska et al. 2016).
Certain phytochemicals are also associated with antihyperlipidemic effect. An
investigation in rats showed reduction of lipid accumulation in liver tissue, which appeared to be
linked with phenolic acids in tart cherry such as chlorogenic acid and more specifically its
metabolites rather than anthocyanins. Such metabolites may have a connection with enzymes of
hypocholesterolemic functions (Papp et al. 2015). In a similar way another study was done with a
cell culture model which explained a dose-dependent influence decreasing lipid accumulation
when the cells are expose to 100 µmol/L of quercetin (Snyder et al. 2016). More studies will be
needed to conclude on the potential antihyperlipidemic and antiadiposity properties of tart cherries.
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Cardiovascular disease

Cardiovascular dysfunction is a leading cause of death among chronic diseases in
industrialized countries. Polyphenol-rich fruits have seen increased interest for potential
cardiovascular health protective effects (Habauzit and Morand. 2012,Habauzit et al. 2015). Tart
cherries kernel extracts were shown to alleviate ischemia reperfusion-induced damage in isolated
rat (Bak et al. 2006) and rabbit (Juhasz et al. 2013) hearts. Only marginal impact was observed
when humans where given similar extracts in a limited double-blind study (Csiki et al. 2015).
An acute, placebo-controlled, double-blinded, cross-over, randomized intervention was
performed in a group of middle age volunteers with early hypertension. Volunteers consumed tart
cherry concentrates (60mL equivalent to 180 cherries). The concentrate consumption was effective
in reducing their systolic blood pressure but not microvascular reactivity nor arterial stiffness. This
effect maybe associated to the phenolic acids content and could be extended to other rich
phytochemical fruits which can serve as systolic blood pressure modulators (Keane et al. 2016b).
Another study reported no detectable effect on the same cardiovascular disease biomarkers,
however the study focused on healthy subjects consuming only 30 mL of the same concentrate
(Lynn et al. 2014).

Other potential health benefits

Tart cherries consumption was shown to improve the working memory in aged rats having
an influence on reducing inflammation linked with aging and therefore promoting delay on
neurodegenerative diseases (Thangthaeng et al. 2016). Furthermore, tart cherry anthocyanins were
reported to accumulate in brain cells of rats after three weeks in a dose-dependent manner as well
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(Kirakosyan et al. 2015). Casedas et al ( 2016) reported that tart cherry juice may have protective
effect against neurological diseases, with antidepressant and anxiolytic properties, possibly due to
the ability to inhibit monoamine oxidase A and tyrosinase. In addition, another study showed
improved memory and cognition in older adults affected with dementia through consumption of
(sweet) cherry juice (Kent et al. 2017)
Tart cherries, in fact all cherries; have been increasingly suggested as beneficial to reduce
the risk of gout attacks, a specific inflammatory arthritis condition. However, FDA has warned
several cherry producers about claims based on unsubstantiated data, and an epidemiological
dietary study provided limited evidence for potential gout protective effect (Zhang et al. 2012) and
a later internet based survey suggested that any correlation seen may be due to the fact that patients
with milder symptoms are more likely to consume cherries or other plant-based supplements and
no treatment, effectively skewing the data (Singh et al. 2015). However, a human study showed
that tart cherry concentrate consumption resulted in significant decrease of plasma uric acid, which
is purported as the main driver of gout attacks (Bell et al. 2014c).

FATE OF CHERRY POLYPHENOLS IN THE DIGESTIVE SYSTEM

It has been assumed for a long time that the impact of polyphenols on health could be identified
by exposing human cell lines to more or less purified fractions from fruits (or other plant material)
(Haddad et al. 2013,Hanbali et al. 2013,Mahmoud et al. 2014,Mahmoud et al. 2013,Martin and
Wooden. 2012, Shukitt-Hale et al. 2016b). However, it is also well known that most polyphenols
cannot be absorbed by cells or reach the blood circulation due to their high molecular size (Moco
et al. 2012a, Marin et al. 2015). In the mammalian digestive system, large non-digestible dietary
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molecules are subject to fermentation, modifications and degradation by the resident microbes
(designed under the terms microbiome or microbiota) (Sheflin et al. 2017). The human colonic
microbiome has therefore become the subject of intense research (Flint et al. 2012,Holmes et al.
2011), in particular in relation to health and diseases (Candela et al. 2014,Carbonero et al.
2012b,Carbonero et al. 2012a,O'Keefe et al. 2015,Everard and Cani. 2013, Sartor. 2008, Kostic et
al. 2014) It is now well known that diet composition strongly influences the gut microbiome
taxonomic composition and metabolic functions (Flint. 2012, Sheflin et al. 2017). A corollary
research field is metabolomics; the study of the metabolites deriving from gut microbe activities
(Wishart et al. 2016, Moco et al. 2012b). The human metabolome is known to include thousands
of small molecules detected in stool, urine and blood; which are far more bioavailable than parent
molecules. As far as we know, there has been no attempt to decipher the impact of tart cherries
consumption on the human gut microbiome and metabolome. Therefore, in this section, we will
describe the potential effects based on published data on relevant pure polyphenols or fruits/plants
with similar polyphenolic profiles.
Polyphenols and polyphenol-rich food impact on the gut microbiota

Several reviews on the impact of dietary polyphenols on the gut microbiota are available
(Duda-Chodak et al. 2015,Tomas-Barberan et al. 2016,Sheflin et al. 2017). The two genera that
are reported the most often as being stimulated by polyphenols are Bifidobacterium and
Lactobacillus, both known for their probiotic properties (Larrosa et al. 2009b,Chen et al. 2016,Li
et al. 2015,Espley et al. 2014,Faria et al. 2014a,Mills et al. 2015). In addition, it has been shown
that those genera are the primary converters of quercetin (Zhang et al. 2014), and chlorogenic acid
(Ludwig et al. 2013), while their role in bioconversion of other polyphenols remains elusive.
Quercetin has been shown to be degraded by Escherichia coli and Bacteroides fragilis (Zhang et
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al. 2014). Isoflavones are converted by Aldercreutzia spp. and Slackia spp (Guadamuro et al.
2017). Elagitannins were found to increase the numbers of Akkermansia in vivo (Li et al. 2015).
Tea, coffee, cocoa, berries mango and pomegranate, all rich in polyphenols were all found to
stimulate Lactobacillus and Bifidobacterium (Jaquet et al. 2009,Bialonska et al. 2010,Ojo et al.
2016,Jakobsdottir et al. 2013,Truchado et al. 2012,Puupponen-Pimiä et al. 2013,van Duynhoven
et al. 2013). The main exception is lingonberries, which have been shown to increase
Faecalibacterium, Bacteroides and Clostridium levels (Heyman-Linden et al. 2016,Matziouridou
et al. 2016).
To the best of our knowledge, there have been no in vitro, animal or human dietary intervention
studies on the impact of tart cherries (and sweet cherries) consumption on the gut microbiome.
Based on cherries polyphenolic profiles, stimulation of Lactobacillus, Bifidobacterium and/or
Bacteroides can be hypothesized, but the bioavailability of specific polyphenols in various tart
cherry products probably influence their impact on gut microbiota. It can be hypothesized that
other phytochemicals would have limited impact because of very low concentration; and the nearabsence of fibers suggests that tart cherries would provide low amounts of polysaccharides for
microbial fermentation.

Microbial derived metabolites from dietary polyphenols

Isoflavones have been studied extensively because microbial biotransformation leads to the
very beneficial equol metabolite (Setchell and Clerici. 2010, Setchell et al. 2002). However, it was
also shown that equol production is not universally distributed (Frankenfeld et al. 2014, Reverri et
al. 2016) leading to the concept of metabotypes. While the potential health benefits of resveratrol
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have been put under scrutiny, it is known that equol producing bacteria are able to convert transresveratrol to dihydroresveratrol (Bode et al. 2013). There is extensive evidence that elagitannins
are converted to urolithins (Espin et al. 2013,Selma et al. 2014,Puupponen-Pimia et al.
2013,Gimenez-Bastida et al. 2012) and proanthocyanidins to phloroglucinol and benzoic acid
derivatives: gallic, syringic and coumaric acids (Faria et al. 2014b,Hanske et al. 2013).
Metabolomics studies have been conducted on different food types. Tea catechins were found
to be converted to conjugated catechins, valerolactones, valeric acids and other phenolic
acids(Grun et al. 2008, Gross et al. 2010). Berries and pomegranate were shown to enrich
metabolomes in urolithins, phloroglucinol and benzoic acid derivatives (Truchado et al. 2012,
Jakobsdottir et al. 2013). Studies on citrus fruits, which are rich in esperetin, naringenin, and ferulic
acid, showed microbial production of different hydroxyphenyl propionic acids(Pereira-Caro et al.
2015).
Chlorogenic acid from coffee was shown to be converted to dihydrocaffeic acid, dihydroferulic
acid, and 3-(3'-hydroxyphenyl) propionic acid in rats (Gonthier et al. 2003) and in humans (Ludwig
et al. 2013). The anthocyanin cyanidin-3-glucoside was shown to be converted mainly to phenolic,
hippuric, phenylacetic, and phenylpropenoic acids in humans through isotope pulse-chase studies
(Czank et al. 2013). These metabolites were shown to modulate vascular reactivity (Edwards et al.
2015) and reducing the expression of inflammatory mediators (Amin et al. 2015) in vitro.
Protocatechuic acid in particular has been reported as the main metabolite of gut microbiota
fermentation of cyaniding glucosides and has been shown to exert several potential health benefits
(Amin et al. 2015,Hornedo-Ortega et al. 2016,Olivas-Aguirre et al. 2016,Wang et al.
2016,Woodward et al. 2011,Seeram et al. 2001b). It is expected that similar metabolites are
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produced through gut microbiota fermentation of tart cherries, though it is possible that the unique
polyphenol profile results in different metabolic pathways and metabolomics profiles.

Conclusions and perspectives

This review provides an update on the current investigation in regard to the promising
phytochemicals content in tart or sour cherries. Improvements in agricultural practices and
processing combined with health claims have resulted increased worldwide production. Health
claims are mainly associated with high polyphenol concentration, as well as specific profile.
However, it is necessary to determine the fate of those polyphenols in the human gastrointestinal
tract. Based on studies on other polyphenol-rich fruits, it is expected that tart cherries consumption
has potential to significantly modulate the gut microbiota composition and metabolic activities,
leading to the release of specific phenolic metabolites. The potential health benefits of modulated
gut microbiota and phenolic metabolites presumably differs from health properties described by
in vitro studies of native polyphenols extracts from tart cherries.
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Table 1: Description of tart cherry juice processing steps.
Processing step

Treatment &
conditions

Aim

Weight data
3.5% reduction in wetweight
2% and 4% reduction
in wet- and dry-weight
bases

Fresh fruit

Washing and selection

Removal of unwanted
material

Fresh fruit and
stalk

Separation of stalks

Stalk removal

Mash heat

Mash heating
80°C for 90s
Pressing; 110barhorizontal press

Enzyme inactivation

No change

Obtaining the juicy
part

73% juice yield

Mash press cake Mash press extractionextract
(repeated 3 times)

Increasing the yield of
juice

Juice yield increased to
85%

Press cake with
seeds

Removal of insoluble
fruit parts

15% reduction wetweight; 29% dryweight

Microbial inactivation

No change

Degradation of pectic
substances and starch
Precipitating haze
precursors
Obtaining the clear
juice by removing
precipitates
Volume reduction for
storage
Elimination of
Alycyclobacillus
bacteria

pectolytic enzyme and
amylolytic enzyme
780 g gelatin/t juice1.2
kg bentonitef/t juice
6% and 7% reduction
in wet- and dry-weight
12.5˚Bx evaporated to
65˚Bx

Mash press

Pasteurized
juice
Enzyme treated
juice
Clarified juice
Filtered juice
and filtration
residue
Concentrated
juice
Non-paperfiltered and
paper-filtered

Press cake resulting
after mash press
Pasteurization of
pressed juice; 95°C for
90s
Enzymation; 50°C for
2h
Clarification; 50°C
for1h
Ultrafiltration
Evaporation to 65˚Brix
(Bx); 65-80°C
Paper filtration

Nectar

Addition of sucrose and
citric acid

Production of nectar

Pasteurized
nectar

Pasteurization of final
nectar; 95°C for 45s

Microbial inactivation
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Negligible
56% sucrose on dryweight basis with:

Table 2: Polyphenols distribution and concentration in the tart cherry fruit..

Cultivar

Montmorency

Portion

Anthocyanins (mg cy-3glu/100gfw)

Total phenolics (mg GAE/g
fw)

ORAC (μmoles
TE/g fw)

FRAP
(μmolesTE/g fw)

Flesh

0 ± 0.1

3.± 0.3

15 ± 1

13.8 ± 0.3

Pits

0.8 ± 0.1

1.6 ± 0.02

9.8 ± 0.3

8.5 ± 0.9

Skins

36.5 ± 1.6

5.6 ± 0.3

51 ± 2

48 ± 1.3

40
40

Table 3: Phytochemical profiles and antioxidant properties in different tart cherries food products.
Product

Total anthocyanin

Phenolic acids

Total phenolic

41

21.5-25.1

147.2-200

45

275.4

19 mmol
TE/Kg

Dried (μg/g)

62-564a

3522-7813b

3.3.5 mmol/L

frozen(μg/g)

533-1741a

6742-12665b

4.4-4.5
mmol/L

Concentrate (μg/g)

213-722a

2541-4013b

3.5 mmol/L

2000-2600
μmol TE/100g
fw

27.8-80.4

(Blando et al. 2004)
(Damar and Eksi.
2012)

21-285

482-1063

Reference
(Nowicka and
Wojdylo. 2016)

Puree (mg/100g)
Fruit (Italian
cultivars)
(mg/100g)
Fruit (Turkish
cultivars)
(mg/100g)
Fruit (Turkish
cultivars)
(mg/100g)

IQF powder(μg/g)

9.3-23.3

Antioxidant
capacity

a

b

7752-10323

Lyophilized juice
(mg/Kg)
0.19
9.84
a
b
dry weight of cyanidin -3-glucoside equivalent; dry weight of gallic acid equivalent

41

(Karaaslan et al.
2016)

(Kirakosyan et al.
2009)

9.8-9.9
mmol/L
(Casedas et al.
2016)

Table 4: Anthocyanins concentrations across varieties and product presentation.
Product
Fruit (Italian
cultivars) (mg/100g)
Fruit (Turkish
cultivars) (mg/100g)
Juice (German and
Hungarian cultivars)
(mg/L)
Juice (Turkish
cultivars) (mg/L)

42

Dry (μg/g)
Lyophilized
juice(μg/g)

Cyanidin-3sophoroside

Cyanidin-3glucosylrutinoside

Cyanidin-3glucoside

Cyanidin-3rutinoside

0.7-2.3

17.3-71.9

0.5-0.9

9.3-25.3

0.48

28.1

1.2

9.2

39-185

361-515

2.6-21.5

140.3-320.9

2-9.9

35.4-85.5

1.9-15.7

11.1-203.6

0.7-7.6

6.9-95.8

125-213

0.08

42

Reference
(Blando et al.
2004)
(Karaaslan et al.
2016)
(Bonerz et al.
2007)
(Damar and
Eksi. 2012)
(Kirakosyan et
al. 2009)
(Casedas et al.
2016)

Table 5: Flavonols profile and concentration in tart cherry products.
Flavonol/Unit

Dry

Frozen

Concentrate

IQF powder

Juice

µg/g

µg/g

µg/g

µg/g

mg/L

Isorhamnetin rutinoside

35.8-383.1

250.2-328.9

163.7-288.1

62.9-176.6

kaempferol

12.9-42.9

3.8-13.1

5.2-11.9

16.8-85.9

Quercetin

1.9-8.8

5.9-8.5

2.1-6.7

556.2-292.6

Melatonin

nd

2.9-12.3

nd

1.7-7.5

14-33
(Kirakosyan et al.
2009)
11-31

Quercetin-3-rutinoside
Quercetin-3-glucoside
Kaemferol-3-rutinoside

18-59
3-8
4-13

43

Quercetin-3-(2glucosylrutinoside

43

References

(Bonerz et al. 2007)

Table 6: Phenolic acids profile in tart cherry.
Sample

Neochlorogenic acid

Chlorogenic acid

Caffeic acid

Author

Fruit (mg/Kg)

584.7

-

33.3

Lyophilized juice
(mg/Kg)

1.6

0.6

(Karaaslan et al.
2016)
(Casedas et al.
2016)

Table 7: Nutrient composition of Tart cherry compared to Sweet cherry (values in 100 grams: Adapted from USDA ARS 2017).
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Nutrient

Unit

Sweet cherry
Value/100 g

Energy

kcal

63

50

Protein
Fiber, total dietary
Sugars, total
Minerals
Vitamin C, total ascorbic acid
Thiamin
Vitamin A, IU
Vitamin E (alpha-tocopherol)
Vitamin K (phylloquinone)

g
g
g
mg
mg
mg
IU
mg
µg

1.06
2.1
12.8
267.4
7
0.03
64
0.07
2.1

1
1.6
8.5
216.4
10
0.03
128
0.07
2.1

44

Tart Cherry
Value/100 g
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ABSTRACT
Tart cherries have been reported to exert potential health benefits, which has been
attributed to their specific and abundant polyphenol content. However, there is a need to study the
impact and fate of tart cherries polyphenols in the gut microbiota. Here, tart cherry, apricots and
pure polyphenols were submitted to in vitro assays and assessed through to 16S rRNA gene
sequence sequencing and metabolomics. A short-term dietary intervention study was also
conducted for microbiota analyses.
Tart cherry concentrate juices were found to contain expected abundances of anthocyanins
and flavonols and high amounts of chlorogenic and neochlorogenic acids. Targeted metabolomics
confirmed that gut microbes were able to degrade those polyphenols, leading to the release mainly
of 4 hydroxyphenylpropionic acid and to lower amounts of epicatechins and 4-hydroxybenzoic
acid. Tart cherries were found to induce a large increase of Bacteroides in vitro, likely due to the
input of polysaccharides, but prebiotic effect was also suggested by Bifidobacterium increase from
chlorogenic acid. In the human study, two distinct and inverse responses to tart cherry consumption
were associated with initial levels of Bacteroides. High Bacteroides individuals responded with a
decrease in Bacteroides and Bifidobacterium, and an increase of Lachnospiraceae, Ruminococcus
and Collinsella. Low Bacteroides individuals responded with an increase in Bacteroides or
Prevotella and Bifidobacterium, and a decrease of Lachnospiraceae, Ruminococcus and
Collinsella. These data confirm that gut microbiota metabolism, in particular the potential
existence of different metabotypes, needs to be considered in studies attempting to link tart cherries
consumption and health.
Keywords: Tart cherry, Apricots; Gut microbiota, Polyphenols; Metabolites.
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INTRODUCTION
Tart cherries (Prunus cerasus) are stone fruits from the rosaceae family which have
become a significant agricultural commodity after centuries of small-scale cultivation [1]. This
increased popularity is due to: (1) greater resistance to environmental factors than other Prunus
species [2], (2) improvements in food processing technologies allowing for the production of less
acidic derived products [3,4] and (3) purported health-promoting properties leading to higher
customer demand [5,6].
Tart cherries, like other red-colored fruits [7], contain remarkably high amounts of
phytochemicals, polyphenols in particular [8-11]. It is well known that plant-derived polyphenols
possess high antioxidant properties [12,13], and this property has led to extensive research on
potential health benefits [14-16]. Tart cherries are particularly rich in anthocyanins and flavonols
like other red-colored fruits [8,17]. A recent study reported that tart cherries may be rich sources
of chlorogenic (3-caffeoylquinic acid (3-CQA)) and neochlorogenic (5-caffeoylquinic acid (5CQA)) acids [18], which have only been described as abundant polyphenols in apricots [19], coffee
[20] and blueberries [21]. Another study described significant amounts of genistein, an isoflavone
typically found in soybeans, in certain tart cherry cultivars [22]. Indeed, there have been numerous
reports of potential health benefits incurred by tart cherries consumption in sport medicine [23,24],
diabetes and metabolic syndrome [25,26] and cardiovascular health in particular [27-29].
However, the antioxidant potential of dietary polyphenols has traditionally been measured
from the native phenolics extracted from the fruits [30,31]. Only a limited fraction of low
molecular weight phenolic compounds can be absorbed in the upper intestinal tract, and those
compounds may have different antioxidant potential than large molecular weight polyphenol
molecules. It is now well established that polyphenolic molecules undergo biotransformation in
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the human colon [32-34]. Those metabolic processes are performed by bacterial members of the
human gut microbiota [35,36]. While ellagitannins bioconversions to urolithins [34] and bacterial
equol production from isoflavones [37] have been studied extensively; there is limited knowledge
on how other polyphenols or polyphenol-rich fruits impact the human gut microbiota and it
metabolic potential [38].
The objective of this study was to investigate the impact of tart cherries and tart cherry juices on
the human gut microbiota composition and to determine the fate of polyphenols through
metabolomics. In vitro fermentations were used to test a variety of cherries and cherry
concentrates. Because it is known that basal gut microbiota composition strongly drives the
metabolism of dietary polyphenols [39], a human dietary intervention was also conducted with
one tart cherry juice concentrate.

MATERIALS AND METHODS
Materials and reagents
Plant materials and pure polyphenols
Concentrate juices (King Orchards) of Montmorency tart cherries grown in Michigan were
provided by the Cherry Marketing Institute. Commercially available tart (Balaton and
Montmorency tart cherries blend; All Natural) and sweet (Black cherries, Tree of Life) cherry
concentrate were also used. Fruits of two tart cherries genotypes (Pipacs1 and Érdi bőtermő)
cultivars harvested in 2010 at the Research and Extension Centre for Fruit Growing (Újfehétró,
Eastern Hungary), were used in this study. In addition, fruits of two apricot (P. armeniaca L.)
cultivars (‘Gönci magyarkajszi’ and m604 cultivars) obtained from 2010 vintage of the apricot
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breeding program conducted at the Department of Genetics and Plant Breeding, Szent István
University (Budapest) were also evaluated.
Reagents
Crystalline 3-caffeoylquinic acid (3-CQA), 5-caffeoylquinic acid (5-CQA), rutin,
kaempferol-rutinoside were purchased from Sigma-Aldrich (St. Louis, USA) and cyanidinglucoside from Extrasynthese (Genay, France). Acetonitrile (HPLC Gradient Grade), methanol
(HPLC Gradient Grade) were obtained from Fisher Scientific (Loughborough, UK) and SigmaAldrich (St. Louis, MO, USA), respectively. Formic acid (98% for mass spectrometry) was
obtained from Fluka (Sigma-Aldrich). High-purity (18 Mcm-1) water was obtained from a MilliQ Plus ultrapure water system from Millipore (Milford, MA, USA).

In vitro digestion experiments
In vitro batch incubations were performed by sampling 25 ml of the distal colon
compartments from the Simulator of the Human Intestinal Microbial Ecosystem (SHIME). This
gastrointestinal model is made of five double-jacketed fermentation vessels simulating the
stomach, small intestine and the three colonic regions conditions [40]. The SHIME was seeded
with enrichment cultures from human stool samples. Microbial suspensions (25 ml) were placed
into bottles containing apricots or cherries (5 mL or g) and were incubated for 48 h at 37 °C. To
maintain anaerobic conditions, l-cysteine (0.5 g/l) was added to bottles before flushing with N2
during 15 cycles of 2 min each at 800 mbar over pressure and 900 mbar under pressure. Bottles
were then closed with butyl rubber stoppers and placed at atmospheric pressure. Samples (1 mL
each) were taken with a syringe and needle at 0, 4, 24 and 48 h. After each sampling, batch cultures
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were flushed with N2 to maintain anaerobic conditions. Samples were centrifuged (14,000g, for
10 min at 4 ºC) and pellets and supernatants were stored at −20 °C until further analysis.

Analytical chemistry
Sample preparation for analytical chemistry
Two hundred µL of fruit juice (Tree of Life, King Orchard or Royal Farms) were diluted to 10 mL
with methanol: water:formic acid (60:39:1, v/v) and ultrasonicated for 30 min at room temperature
(< 35 °C at the end). After centrifugation at 3,000g for 10 min, 2.5 mL of the supernatant was
diluted to 5 mL with water, and filtered through a 0.2 μm PTFE filter (SMI-LabHut Ltd,
Gloucester, U.K.) before injection on the analytical column for analysis.
Apricot and cherry fruits were halved after harvesting; stones were removed and stored at -80 °C
until lyophilization. Lyophilized samples were manually pulverized in a mortar and stored at -20
°C until dilution of 200 mg into 10mL of methanol: water:formic acid (60:39:1, v/v). Sample
preparation was then performed as described in the previous paragraph.
Fluids (from simulated stomach, small and large intestine) of in vitro digestions were
homogenised after thawing, and 250 µL mixed with 725 µL MeOH containing 1% (v/v) formic
acid and 25 µL daidzein internal standard (50 µg mL-1). Samples were homogenised for 30 secs
using a vortex mixer, then centrifuged at 15,000g (10 min, 4°C). After centrifugation, 500 µl
aliquots of the supernatant were transferred to clean micro-centrifuge tubes and concentrated to
final volumes below 200 µL with a speed-vacuum. Then 25 µL of MeOH containing 5 % (v/v)
formic acid was added final volume adjusted to 250 µL with water. Finally, samples were filtered
through a 0.2 μm PTFE filter before injecting 10 μL on the analytical column for analysis.
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LC/MS analysis
The LC/MS profiling of fruit juices and in vitro gastric samples were based on the approach
detailed previously [19,22]. The HPLC system (Agilent 1200, Agilent Technologies, Waldbronn,
Germany) including a binary pump and a diode array detector (DAD) was coupled to an Agilent
6350 quadrupole–time-of-flight

(Q/TOF) hybrid tandem mass spectrometer

(Agilent

Technologies, Santa Clara, CA USA) equipped with a dual-spray ESI source. Chromatographic
separation was carried out on a Phenomenex Kinetex Phenyl-hexyl RP (Phenonemex,
Macclesfield, UK), 4.6 × 150 mm, 2.6 μm particle size column using 0.5% (v/v) formic acid in
water (mobile phase A) and 0.5% (v/v) formic acid in acetonitrile (mobile phase B) as mobile
phases at a flow rate of 500 μL/min. The gradient program was started at 8% B and after 5 min of
isocratic run, solvent B was increased linearly and reached 45 % at 35 min and then 100 % at 40
min. Finally, 100% B was kept constant for 5 min, followed by 10 min isocratic re-equilibration
for initial conditions.
Mass spectrometer was used either in negative or positive ion mode, with the following
parameters: electrospray capillary voltage, 4000 V; nebulizer pressure, 40 psig; drying gas flow
rate, 13 L/min; gas temperature, 325 C; skimmer voltage, 65 V. Fragmented voltage was triggered
automatically between 160 V and 210 V in positive mode and 140 and 240 V in negative mode.
The instrument performed internal mass calibration automatically, using a reference ESI nebulizer
with an automated calibrating delivery system, which introduces the flow from the outlet of the
chromatograph together with a low flow of a calibrating solution. The calibrating solution contains
internal reference masses of purine and HP-0921 ([hexakis-(1H,1H,3H-tetrafluoropentoxy)phosphazene]). Protonated molecules of purine ([C5H5N4]+ at m/z 121.0509) and HP-0921
([C18H19O6N3P3F24]+ at m/z 922.0098) were used as reference masses in positive ion mode, while
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deprotonated purine at m/z 119.0363 and the formate adduct of HP-0921 ([C19H19O8N3P3F24]- at
m/z 966.000725) were used for the same purpose in negative ion mode.
High resolution (> 20 000 FWHM at m/z 922) full-scan TOF spectra were recorded in the
range of m/z 50–1100 at a frequency of 1.4 spectra/s. Agilent Mass Hunter Qualitative Analysis
Software (version B.04.00 build 3.1.346.0) was applied for data evaluation. The DAD acquired
data in the range of 200-800 nm in 2-nm steps at 0.5 spectra/s acquisition speed.

Quantitative determination of selected polyphenols
Quantitation of chlorogenic acid (3-CQA), neochlorogenic acid (5-CQA), rutin, kaempferolrutinoside, was carried out using the standard addition calibration technique and reference
standards, whereas cyanidin-dH-H-H, Cyanidin-dH-H and cyanidin-glucoside were all quantified
as cyanidin-glucoside equivalents. Anthocyanins, rutin and kaempferol-rutinoside were quantified
in positive ion mode using the [M+H] + ion, whereas 3-CQA and 5-CQA were quantified in
negative ion mode based on their [M-H]- ions.

Dietary intervention

The study was approved by the University of Arkansas IRB (IRB# 15-02-476). A cohort
of 10 healthy participants of five of each gender from 23 to 30 years old were recruited. All
individuals took part in a screening session where they signed a consent form and completed a
Food Frequency Questionnaire (FFQ). The individuals where generally healthy, with normal
digestive function, non-smokers, and had not consumed any type of antibiotics for twelve weeks
prior and during the intervention Each individual received tart cherry concentrate (King Orchard,
52

provided by the Cherry Marketing Institute) for the length of the study. Subjects were instructed
to consume 8 oz of juice daily for five days. Additionally, they received a stool collection kit
(commode Specimen Collection System; Fisher Scientific, Pittsburg, PA, USA) and provided a
stool samples before and after the dietary intervention. Once the samples were collected they were
stored at -80°C until analysis.
Microbial Analyses
DNA extraction
Bacterial DNA was extracted and purified from the stool samples with the QIAamp Fast
DNA Stool Mini Kit (Qiagen, Valencia, CA) following the manufacturer’ recommendations with
addition of an initial bead-beading step (autoclaved 100 mg of 0.1 mm and 0.5 mm diameter
Zirconia-silicate beads - BioSpec Products) for 30 s at 30 Hz repeated 3 times using FastPrep-24
sample preparation system (MP Biomedical, CA) [41]. The genomic DNA quantification was
measured with a Qubit Fluorometer (Life Technologies, Carlsbad, CA). A polymerase chain
reaction (PCR) was set up in a 96 well plate for confirmation of the bacterial DNA quality with
universal 8F and 1541R primers for bacteria [42]. The quality was checked with 12% of samples
randomly selected on a gel electrophoresis of 1% agarose gel to ensure amplification was normal
and verify the presence of bacterial DNA from the stool sample [43].
Library Preparation for sequencing
After bacterial DNA quality check, a second polymerase chain reaction (PCR) was
performed to amplify the V4 region of the 16S rRNA gene using dual-indexed Illumina primers
[43]. PCR reaction mixtures were set up with Accuprime Pfx SuperMix (Life Technologies,
Carlsbad, CA) according to the manufacturer’s protocol, forward and reverse primers (200nM final
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concentration) and template DNA (15 ng) in a 96 well plate; each plate contained a negative control
(water). The amplification was carried out in an Eppendorf Mastercycler pro S (Eppendorf) under
the following conditions 95°C for 5 min for initiation with 30 cycles of thermal program
(denaturation, 95°C for 30 s; annealing, 55°C for 30 s; extension, 72°C for 60 s) and finally 72°C
for 5 min. Then all samples were run in a 1% gel electrophoresis at 100v for 40 min for quality
control of the PRC product.
Normalization and purification of the amplicon was performed using Invitrogen
SequalPrep Kit (Life Technologies, Carlbad, CA) following the manufacturer’s recommendations
in order to remove residual salts or short oligonucleotide primers and normalize the concentration.
To ensure success of the step a 1% gel electrophoresis was run with all the samples. Then, aliquots
of 5 μL of each sample were pooled together. Pooled samples quality was checked on a
TapeStation (Agilent). Real-time quantitative PCR was performed using Eppendorf Realplex
Mastercycler ep gradient S (Eppendorf, Hamburg, Germany) using the PerfeCta NGS library
Quantification Kit (Quanta Biosiences, Beverly, MA) according to the manufacturer’s protocol.
The prepared library was mixed and diluted with 0.2 N NaOH and HT1 buffer, along with
the control mix of PhiX control V4 and both solutions brought up to 8 pM of final concentration.
The diluted amplicon and control were combined and loaded to the Illumina Miseq reagent
cartridge along to the index, read 1 and read 2 sequencing primers.
Sequence and Statistical Analysis
The sequencing reads were downloaded from the Illumina Basespace server in Fastq files
format. The sequences were demultiplexed in read 1 and read 2 with approximately 250bp in
length. The sequencing analyses were carried out using SILVA database as reference for
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assignation of operational taxonomic units (OTUs) with 97% of identity. Further analysis was done
using Mothur 1.35.1 pipeline [44]. Non-metric multidimensional scaling (NMDS) plots and
analysis of similarities (ANOSIM), both based on the Bray-Curtis index, were obtained in PAST
3.15. In addition, Kruskal Wallis and Mann-Whitney tests were performed to detect significant
differences in bacterial taxa between samples and time points (by convention, differences were
considered significant when p<0.05).
RESULTS AND DISCUSSION
Tart cherry juices phenolic profiles

To the best of our knowledge, this is the first time that concentrated juices of Montmorency
and Balaton tart cherries grown in the U.S. were profiled for their phenolic content. In comparison
with previous studies on sweet cherries or European sour cherries, profiles were similar in the
composition of anthocyanins, hydroxycinnamic acids and flavonols (Table 1) [4,17,45,46]. The
most notable difference was the absence of detection of catechins and epicatechins which were
reported in European sour cherries cultivars. While anthocyanins have received more attention for
tart cherries, we report here that the most abundant polyphenols in the concentrated juices were
the hydroxycinnamic acids: chlorogenic (3-CQA) and neochlorogenic (5-CQA) acids (Table 1).
Remarkably, 3-CQA, but not 5-CQA was much less abundant in the sweet cherry concentrated
juice. The only other food containing high levels of 3-CQA are coffee [20,47,48], apricots [49]
and blueberries [21].
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Polyphenol degradation and associated phenolic metabolites in vitro

As expected, in the initial stages (stomach and small intestine SHIME compartments), 3CQA, quercetin-3-O rutinoside and glucoside, and kaempferol-rutinoside were among the most
abundant polyphenols. However, metabolomics also revealed the presence of significant amounts
of catechin and epicatechin in tart cherry concentrates only, indicating that tart cherry contained
tannins (Figure 1A). Somewhat surprisingly, the concentration of those polyphenols decreased
significantly in the stomach and small intestine. The concentration of all the detected native
polyphenols declined steadily with time in the colonic fermentation, confirming that resident
microbiota was responsible for their bioconversion.
3-CQA catabolism was somewhat constant during the 48 hr of fermentation. 3-CQA
derivatives included caffeic acid at very low concentrations, but the main metabolite was dihydrocoumaric acid (Figure 1B) as described before [50,51].In the early stages of the SHIIME
experiment, large amounts of 4-hydroxyphenylacetic acid were detected and decreased to stable
amounts in the colon compartment (Supplementary Figure 1), which makes it difficult to assess if
this metabolite originates from bacterial metabolism. However, this metabolite is known to derive
from quercetin and kaempferol from different berries [52]. At this point, very small amounts of
quercetin-3-O-glucoside were detected compared with quercetin-3-O-rutinoside and kaempferol3-O-rutinoside that were still present at higher concentrations. The rutinoside derivatives
concentrations decreased subsequently, suggesting that gut microbes preferentially used the
glucoside forms before the rutinosides. Quercetin was apparently converted to 3,4 and 4hydroxybenzoic acid, but catechins may represent another origin for these metabolites (Figure 1B),
as both pathways have been described [53].
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Impact of tart cherries and apricots on gut microbiota in vitro

A total of 68 samples were subjected to DNA extraction and sequencing (replicate samples
derived from concentrated juices and control were also sequenced due to low read counts in the
first sequencing run). Overall 202,239 high quality reads (2974±1760) were obtained, 192,459
(3262±1700) when excluding low read (<1,500) counts.
The control fermentation with only stool samples yielded a low diversity microbiota dominated by
Verrumicrobia then Synergistes (Figure 2A), two marginal phyla in the human colon. Remarkably,
the two major genera present in the control fermentation, Akkermansia and Cloacibacillus
(Supplementary Figure 2) are well known for their strict metabolism of feeding from host-derived
mucins rather than dietary elements in the lumen [54-56]. In addition, Bifidobacterium
(Actinobacteria), present in relatively high abundance, have also been shown to be able to feed on
host mucins [57,58], and the third most abundant genera, Bilophila, is able to metabolize host bile
acids [59,60]. It appears that fermentation of dietary elements present in the batch cultures was
primarily conducted by Bacteroides and several members of the Firmicutes in succession
(Veillonella (0hr), then Lachnospiraceae (4-24 hr) and Lachnospiraceae, Eubacteriaceae and
Clostridium XIVa (48 hr). Somewhat surprisingly, some genera typically present in high
abundance and known as polysaccharides and fiber fermenters [61-63] were detected in marginal
relative abundance (though it does not mean they were not active), in particular Prevotella and
Ruminococcus.
As expected, fermentation with polyphenols and to a greater extent with fruit matrices significantly
shifted the microbiota, primarily with a dramatic and consistent decrease in Verrumicrobia then
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Synergistes and increase in Bacteroidetes primarily, and to a lesser extent Firmicutes and
Proteobacteria (Figure 2B-D).
Impact of tart cherries powder and tart cherries concentrated juices

All tart and sweet cherries products lead to similar gut microbiota modulation (Figure 3A),
driven by very significant increase of Bacteroides relative abundance at all time-points (Figure
3B), probably reflecting fermentation of sugars and carbohydrates which are the main energy
source for Bacteroides [64]. Other genera that were significantly increased included Veillonella,
Bilophila Enterobacteriaceae and Escherichia and Clostridium XIVa. These dynamics probably
reflects carbohydrates fermentation rather than plolyphenols biotransformation.
Similar trends were observed for sweet cherry juice (Supplementary Figure 2), however the
increase in Bacteroides was less marked, and Clostridium XIVa, Lachnospiraceae and
Eubacteriaceae increased slightly, presumably because of the higher sugar and polysaccharides
content of this juice.
Impact of apricot powder on the gut microbiota

Apricots have been shown to contain high amounts of 3-CQA, and to be generally rich in
a diversity of polyphenols [19,49]. Two apricot varieties were subjected to in vitro fermentation
and induce a very significant modulation of the gut microbiota (Figure 4A). As with tart cherries,
apricots fermentation resulted in an overwhelming increase of Bacteroidetes (Figure 1B),
Bacteroides in particular (Figure 4B). Remarkably, and in contrast with tart cherries, a significant
increase of Lactobacillales, Lactobacillaceae and Lactobacillus (around 15%) was observed after
48 hours of fermentation. While Lactobacillus has been identified as able to metabolize 3-CQA
[66], this is to the best of our knowledge the first time that a very strong potential prebiotic impact
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is suggested for apricots. However, it should be reminded that 48 hours in vitro fermentation may
not really be representative of in vivo metabolism, and thus further analyses with apricots would
be needed.
Impact of representative pure polyphenols
Since the microbiota in cherries’ batch fermentation were likely more influenced by
nutrient than polyphenol content, representative polyphenols were subjected to similar
fermentation to better determine their potential impact on human gut microbiota. Indeed, gut
microbiota dynamics was different in terms of abundance (Figure 5), but with similar responsive
taxa.
As confirmed by our concentrated juices’ polyphenols profiling, tart cherries are
particularly rich in 3-CQA and 5-CQA yielded a notable increase in Bifidobacterium in the first
three time-points (Supplementary Figure 7), which is in accordance with previous reports of
Bifidobacterium species’ ability to catabolize CA [48,67,68]. However, these studies also reported
Lactobacillus species as common CA degraders [69], while in our case there was no visible change
in Lactobacillus and other lactic acid bacteria (if anything, there was often a very slight decrease).
Other taxa stimulated included Bacteroides to a small extent, Bilophila, Veillonella and members
of the Clostridium XIVa cluster. The latter observation lines up with the report of increased
Clostridium coccoides-Eubacterium rectale group by pure 3-CQA [48]. Bacteroides has been
reported as a primary degrader of complex carbohydrates that are used as source of energy [64].
The stimulation of Veillonella and Bilophila is more enigmatic. As a lactate fermenter [70,71], the
increase of Veillonella may be explained by cross-feeding on lactate produced by Bifidobacterium,
however lactate production has only been shown from oligosaccharides in Bifidobacterium [72].
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Bilophila is known to ferment polysaccharides with taurine or hydrogen as final eletron acceptors
[73]. It is thus possible that Bilophila disposes of the hydrogen released through fermentation of
dietary molecules, a process that would likely be performed by other hydrogenotrophic bacteria
and archaea in vivo [74,75].
Quercetin-rutinoside (QR) was the second most abundant polyphenol in concentrated tart
cherry juices. Somewhat similarly to, QR led to an increase in Bacteroides, Bifidobacterium,
Veillonella and Bilophila (Supplementary Figure 8). The most notable difference was a strong
increase in members of Clostridium cluster XIVa with a peak at 4hr, mirroring the Bifidobacterium
dynamics. It seems likely that Clostridium XIVa cross-feed on rutinoside derived from
Bifidobacterium [76,77] and possibly Bacteroides breakdown of QR, while Bilophila disposed of
hydrogen produced by this fermentation.
To the best of our knowledge, cyanidin rutinoside impact on human gut microbiota was
never tested before. Cyanidin rutinoside resulted in a marked increase of Bacteroides, but limited
bifidogenic effect (Supplementary Figure 8). Veillonella and Clostridium XIVa were again
stimulated as well as Bilophila, presumably because of similar metabolic requirements and
properties as described for QR.
While genistein was not measured in the tart cherry concentrates, its abundance has been
shown in other tart cherry cultivars [22]. Genistein (Supplementary Figure 9) induced a significant
bifidogenic effect as well as increases of Collinsella and Assacharobacter, which have been
reported as degraders of isoflavones that do not produce equol [78].
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Since Bifidobacterium relative numbers were not affected in contrast with other mucin degraders,
we can hypothesize that polyphenols in tart cherries and concentrates were to a certain extent
metabolized by Bifidobacterium.
Impact of tart cherries on gut microbiota in vivo
One individual’s sample yielded very low read counts, and thus sequences from nine subjects
were analyzed. A total number of 124,172 high quality reads (6898±2455) were obtained. When
comparing all individuals before and after dietary intervention, very little difference in microbiota
was observed (Supplementary Figure 10). However, it was found that individuals initial microbiota
were highly variable, with the relative abundances of Bacteroides being the main driver. Since
Bacteroides was the genus primarily impacted by concentrated juice in vitro, it was decided to
split the individuals in two groups: low (<10%; n= 4; LB) and high (>20%; n= 5; HB) Bacteroides
in the initial gut microbiota (it should be noted that no individual exhibited relative abundance
between 10 and 20%). Separating human cohorts according to their enterotypes [79,80] or
metabotypes [39,81] is an increasingly common approach to overcome the inherent interindividual
variability in gut microbiota profiles. Here, we observed that the microbiota were significantly
different (ANOSIM: p<0.05) before and after dietary intervention among both groups (Figure 6)
In addition, the grouping revealed significant differences in dietary habits, with higher intake of
carbohydrates, sugar and fibers associated with LB (and high Firmicutes) gut microbiota (Table
2). LB individuals also tended to have lower BMI.
At the phylum level, the HB group initially had higher Bacteroidetes than the LB, and LB had
more Firmicutes. In the HB group, tart cherry consumption resulted in a sharp significant decrease
of Bacteroides, Parabacteroides and Alistipes, as well as suggestive decrease of the low abundant
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Barnesiella, Butyricimonas, Odoribacter, Porphyromonas and other Prevotellaceae (Figure 7A).
These trends were mirrored with significant or suggestive increases in many Firmicutes
(Ruminococcus, Lachnospiraceae, Clostridium and Clostridium XI, Dialister, Coprococcus,
Lactobacillus and Streptococcus), with the notable exception of a significant decrease in
Faecalibacterium relative abundance. Somewhat surprisingly, Bifidobacterium numbers tended to
decrease, but a significant increase in other Actinobacteria and Collinsella was observed.
Remarkably, the dynamics were almost completely opposite in the LB group (Figure 7B). All
abundant Bacteroidetes genera increased though generally only in a suggestive manner. In
particular it should be noted that the apparent increases in Prevotella for each group was entirely
driven by one individual in each group increasing from less than 1% to more than 15%. Prevotella
is considered a major genus in driving “enterotypes”, and has been consistently associated with
consumption of plant-rich diets [82-86]. More specifically, it was shown that short-term dietary
intervention with “extreme” plant-based diets can drive strong Prevotella expansion, with
responsiveness varying greatly between individuals [62], in agreement with our findings. The
increase in Bacteroidetes genera was mirrored with decreases in some Firmicutes members
(Lachnospiraceae, Streptococcus, Dialister, Blautia and Roseburia), however, increase in
Clostridium IV and XI, Subdoligranulum and Lactobacillus (numerical) were also observed.
Bifidobacterium relative abundance increased numerically, associated with significant decrease in
Collinsella and suggestive decrease in Assacharobacter and other Actinobacteria. Therefore, the
only common response for the HB and LB were a maintenance or slight increase of Ruminococcus
and a sharp decrease of Faecalibacterium. Ruminococcus are well known to degrade complex
polysaccharides (cellulose, xylan, pectins…) and dietary fibers in the human colon [61,63], while
Faecalibacterium has been particularly associated with high fiber consumption [87-89]. Since tart
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cherry juice contains no dietary fiber, these trends may be due to lower dietary fiber intake by the
subjects during the dietary intervention, because of the important fruit intake through juice
consumption. Since the HB group had lower regular intake of carbohydrates, it is likely that the
large intake of complex polysaccharides stimulated Lachnospiraceae and other Clostridiales
typically involved in the metabolism of those molecules [90-92]. It appears that in HB individuals,
high 3-CQA and 5CQA intake selected more Collinsella than Bifidobacterium, bringing more
evidence for Collinsella’s potential role in polyphenol degradation. The LB group response was
more in line with the In vitro dynamics, indicating that the donor(s) gut microbiota was likely
similar. It can be hypothesized that the LB response is more driven by the high polyphenol intake,
since their gut microbiota was presumably adapted to higher complex polysaccharides intake. The
increases in Bacteroides and Bifidobacterium would then be explained by their known abilities to
metabolize 3-CQA, 5-CQA and many polyphenols present in tart cherries [93-97]. Based on
previous studies [66,98], a significant increase may have been expected in Lactobacillus, however
Lactobacillus were, surprisingly, not prevalent and abundant in this human cohort.

CONCLUSIONS
To the best of our knowledge, this study represents the first microbiota/metabolome
investigation of the impact and fate of tart cherries and their polyphenols in the human colon. The
metabolomics from in vitro fermentation showed that 3-CQA and 5-CQA, the dominant
polyphenols, were mainly converted to dihydrocoumaric acid. In vitro fermentation of tart cherry
powder and concentrated juices (and apricots) resulted in large increases in Bacteroides and
Collinsella and moderate increases of specific Firmicutes, Enterobacteriaceae and Bilophila. In
vitro fermentation of pure polyphenols indicated bifidogenic effects for 3-CQA and 5-CQA,
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genistin and to a lesser extent rutin and cyanidin. Bacteroides appeared to be more involved in
rutin and cyanidin metabolism. The human dietary intervention demonstrated strikingly different
responses due to initial microbiota composition, apparently driven by individuals’ habitual
consumption of carbohydrates and fiber. The high Bacteroides group (low carbohydrates and fiber)
responded to tart cherry juice consumption with decrease of Bacteroides and increase of
fermentative Firmicutes and potential polyphenol metabolizer Collinsella. The low Bacteroides
group responded with an increase in Bacteroides and Bifidobacterium (presumably due largely to
polyphenols availability) and decrease in in the relative abundance of fermentative Firmicutes.
Overall, our results confirm that gut microbiota strongly influences polyphenol metabolites
from polyphenol-rich tart cherries in the human colon. Further, the data suggests that gut
microbiota of individuals consuming a more Western diet may have lower ability to metabolize
polyphenols, thereby reducing bioavailability and any potential health benefits.
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Table 8: Phenolic profiling of cherry concentrated juices (NQ: Not quantified).
Phenolic compound

Concentration (mg/100g)
King
Royal
Tree of Life
Orchard
Farms
25.5±1.9 22.8±1.9
3.6±0.1
21.1±2.5 33.9±1.8
39.2±5.5
NQ

Chlorogenic acid
Neochlorogenic acid
Caffeoyl-quinic acid
isomers
Hydroxycinnamic Coumaroyl-quinic acid
acids
isomers
Feruloylquinic acid

NQ
NQ

Di-caffeoyl-quinic acid

Flavonoid

NQ

Rutin
Kaempferol-rutinoside
Quercetin-deoxyhexose-exose-hexose
Isorhamnetindeoxyhexose-hexose

10.3±0.5
3.6±0.3

6.0±0.1
1.9±0.1

5.0±0.2
0.8±0.1
NQ
NQ

Keracyanin*
1.4±0.2
0.3
1.4±0.0
Cyanidin-dH-H-H*
4.9±0.3
4.4±0.2
<0.02
* Cyanidin compounds quantification was carried out based on cyanidin-glucoside standard,
therefore given concentrations are cyanidin-glucoside equivalents.
Anthocyanidins
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Table 9: Demographic and dietary intake data of the High and Low Bacteroides groups.
Gender
Age
BMI
Avg FBG
kilocalories
Protein (g)
CHO (g)
Fat (g)
Alcohol (g)
Cholesterol (mg)
SFA (g)
MUFA (g)
PUFA (g)
PRO %
CHO %
Fat %
Alcohol %
Fiber (g)
Sugar (g)

High Bacteroides
3M-2F
26.2
26.1
90.1
1543
75
134.4
70.3
12.6
279.2
21.3
28.1
15.5
19.42
34.3
40.4
5.86
10.8
51.2

Low Bacteroides
1M-2F
25.5
22
89.6
1830
75
197.6
83.5
3.4
362.2
27.3
32.6
17.1
16.2
42.2
40.3
1.3
21.62
78.9
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T-test
0.379
0.068
0.445
0.161
0.49
0.049
0.2
0.038
0.182
0.122
0.26
0.342
0.152
0.034
0.488
0.028
0.04
0.018

Figure 1: Polyphenol metabolomics; Microbial degradation of the main native tart cherry
polyphenols over the 48 hours of microbial fermentation in vitro A and B. Tart cherry and C.
Sweet cherry concentrate juices; and detection of major metabolites from chlorogenic acid (DEF)
and proanthocyanins (GHI) for King Orchard (DG) and All Natural (EH) tart cherry juices and
Sweet cherry juice (FI).
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Figure 2: Dynamics (phylum level) of microbiota in in vitro fermentation for A. Control, B.
Apricots, C. All tart cherries and D. all polyphenols standards.
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Figure 3: Tart cherries impact on in vitro gut microbiota. (A) Non-metric Multidimensional
Scaling (NMDS) of control (filled squares), tart cherries (+) and sweet cherries (filled circles);
(B) Relative abundances of significantly modulated taxa for all tart cherries samples
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Figure 4: Apricots impact on in vitro gut microbiota. (A) NMDS of control (filled squares), and
apricots (open diamonds); (B) Relative abundances of significantly modulated taxa for all
apricots samples.
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Figure 5: Pure polyphenols impact on in vitro gut microbiota: relative abundances of
significantly modulated taxa.
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Figure 6: Stool microbiota dynamics (NMDS and phylum level) for human volunteers with A.
High Bacteroides and B. Low Bacteroides initially; before (green) and after (red) dietary
intervention with daily tart cherry juice consumption
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Figure 7: Bacterial genera significantly affected by tart cherry consumption for A the high
Bacteroides group and B the low Bacteroides group.
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Chapter 3
OVERALL CONCLUSION

The results of this research provide evidence and confirm an active intervention of the gut
microbiota over the metabolism of polyphenols contained in tart cherry concentrate juices as
well as fresh fruits. Additionally, the initial gut microbiota composition of an individual
determines the ability to metabolize efficiently polyphenols into bioactive microbial metabolites
with potential health benefits. Finally, such approaches are suggested when studying the
association of polyphenols over any health claims.
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